We are live on ! Find out more
Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings

AUM $43.4B
1-Year Est. Return 51.29%
This Fund
S&P 500
This Quarter Est. Return
+0.51%
1 Year Est. Return
+51.29%
3 Year Est. Return
+133.48%
5 Year Est. Return
+173.9%
10 Year Est. Return
+551.09%
AUM
$14.6B
AUM Growth
-$1.02B
Cap. Flow
-$902M
Cap. Flow %
-6.19%
Top 10 Hldgs %
33.67%
Holding
1,168
New
194
Increased
342
Reduced
403
Closed
225

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$56M
2
CSCO icon
Cisco
CSCO
+$49.4M
3
META icon
Meta Platforms (Facebook)
META
+$45.4M
4
CVE icon
Cenovus Energy
CVE
+$40.5M
5
BNS icon
Scotiabank
BNS
+$39.8M

Sector Composition

Rank Sector Weight
1 Financials 27.48%
2 Energy 13.55%
3 Industrials 13.52%
4 Technology 10.79%
5 Materials 8.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBIO
651
Crescent Biopharma
CBIO
$618M
$575K ﹤0.01%
+1,335
New +$859K
JWN
652
DELISTED
Nordstrom
JWN
$572K ﹤0.01%
+17,000
New +$519K
FDS icon
653
Factset
FDS
$10.2B
$571K ﹤0.01%
+2,350
New +$652K
EA
654
DELISTED
Electronic Arts
EA
$570K ﹤0.01%
5,825
-8,250
-59% -$775K
SNR
655
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
$567K ﹤0.01%
84,815
-162,750
-66% -$1.08M
GSB
656
DELISTED
GlobalSCAPE, Inc.
GSB
$567K ﹤0.01%
49,400
+33,050
+202% +$383K
SLM icon
657
SLM Corp
SLM
$5.22B
$565K ﹤0.01%
64,050
-44,025
-41% -$396K
TARO
658
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$564K ﹤0.01%
7,475
+1,175
+19% +$95.4K
PFNX
659
DELISTED
Pfenex Inc.
PFNX
$563K ﹤0.01%
66,733
-7,347
-10% -$53.3K
CVEO icon
660
Civeo
CVEO
$344M
$558K ﹤0.01%
36,603
-890
-2% -$15.7K
WAL icon
661
Western Alliance Bancorporation
WAL
$8.92B
$558K ﹤0.01%
12,100
-7,800
-39% -$352K
PLAB icon
662
Photronics
PLAB
$1.97B
$552K ﹤0.01%
50,700
+14,575
+40% +$141K
BMRN icon
663
BioMarin Pharmaceuticals
BMRN
$13.3B
$551K ﹤0.01%
8,175
+2,875
+54% +$221K
CHH icon
664
Choice Hotels
CHH
$4.71B
$543K ﹤0.01%
+6,100
New +$544K
LE icon
665
Lands' End
LE
$390M
$542K ﹤0.01%
+47,775
New +$504K
EQT icon
666
EQT Corp
EQT
$33.8B
$541K ﹤0.01%
+50,805
New +$655K
MFA
667
MFA Financial
MFA
$931M
$541K ﹤0.01%
+18,363
New +$535K
PVG
668
DELISTED
PRETIUM RESOURCES INC.
PVG
$537K ﹤0.01%
46,600
-518,595
-92% -$6.16M
BGSF icon
669
BGSF Inc
BGSF
$59.2M
$526K ﹤0.01%
27,549
-1,300
-5% -$24.2K
SIRI icon
670
SiriusXM
SIRI
$9.43B
$526K ﹤0.01%
8,412
+1,570
+23% +$96.6K
EGY icon
671
Vaalco Energy
EGY
$592M
$522K ﹤0.01%
256,940
-73,102
-22% -$129K
REGI
672
DELISTED
Renewable Energy Group, Inc.
REGI
$519K ﹤0.01%
+34,575
New +$477K
RC
673
Ready Capital
RC
$294M
$515K ﹤0.01%
32,375
+3,200
+11% +$48.5K
CLR
674
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$515K ﹤0.01%
+16,713
New +$565K
MMS icon
675
Maximus
MMS
$2.94B
$510K ﹤0.01%
6,600
-5,300
-45% -$402K

Similar funds

Connor, Clark & Lunn Investment Management (CC&L)'s Q3 2019 Portfolio in Review

As of Q3 2019, Connor, Clark & Lunn Investment Management (CC&L) held 1,168 positions worth $14.6B, down 6.5% from $15.6B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Connor, Clark & Lunn Investment Management (CC&L) withdrew a net $902M in Q3 2019, closing 225 positions and reducing 403 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $37.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 27% a quarter earlier, followed by Energy and Industrials.

Against the trend, Connor, Clark & Lunn Investment Management (CC&L) opened a new position in Fidelity National Information Services worth $29.9M.

  • Connor, Clark & Lunn Investment Management (CC&L)'s largest Q3 2019 buy was Fidelity National Information Services: 225,271 shares worth $29.9M.
  • Connor, Clark & Lunn Investment Management (CC&L) added most to Pfizer in Q3 2019, an estimated $56M increase.
  • Connor, Clark & Lunn Investment Management (CC&L)'s biggest Q3 2019 reduction was Toronto Dominion Bank, cutting an estimated $105M.
  • Connor, Clark & Lunn Investment Management (CC&L) fully exited Bristol-Myers Squibb in Q3 2019, selling an estimated $37.2M.
  • Connor, Clark & Lunn Investment Management (CC&L)'s ten largest holdings make up 34% of its $14.6B portfolio in Q3 2019.
  • Connor, Clark & Lunn Investment Management (CC&L) opened 194 new positions and closed 225 in Q3 2019.
  • Connor, Clark & Lunn Investment Management (CC&L)'s portfolio value fell 6.5% quarter-over-quarter to $14.6B.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2019, filed 13 Nov 2019.